Related references
Note: Only part of the references are listed.Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration
Kina Hoglund et al.
NEUROBIOLOGY OF DISEASE (2020)
Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials
Adam M. Staffaroni et al.
BRAIN (2019)
Cognitive aging is not created equally: differentiating unique cognitive phenotypes in normal adults
Kaitlin B. Casaletto et al.
NEUROBIOLOGY OF AGING (2019)
Targeting Synaptic Plasticity in Experimental Models of Alzheimer's Disease
Dalila Mango et al.
FRONTIERS IN PHARMACOLOGY (2019)
Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
Daniel Alcolea et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
Suzanne E. Schindler et al.
ALZHEIMERS & DEMENTIA (2019)
CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia
Mica T. M. Clarke et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
Douglas Galasko et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Person-Specific Contribution of Neuropathologies to Cognitive Loss in Old Age
Patricia A. Boyle et al.
ANNALS OF NEUROLOGY (2018)
Religious Orders Study and Rush Memory and Aging Project
David A. Bennett et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Neurogranin as a predictor of memory and executive function decline in MCI patients
Alison Headley et al.
NEUROLOGY (2018)
Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers
Kaitlin B. Casaletto et al.
NEUROLOGY (2017)
Tau association with synaptic vesicles causes presynaptic dysfunction
Lujia Zhou et al.
NATURE COMMUNICATIONS (2017)
Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data
Charles C. White et al.
PLOS MEDICINE (2017)
Dendritic spines provide cognitive resilience against Alzheimer's disease
Benjamin D. Boros et al.
ANNALS OF NEUROLOGY (2017)
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood
Kaj Blennow
NEUROLOGY AND THERAPY (2017)
Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer's disease spectrum
Ashley Swanson et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss
Tara E. Tracy et al.
NEURON (2016)
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
Annika Ohrfelt et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Prevalence of Amyloid PET Positivity in Dementia Syndromes A Meta-analysis
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Neuronal activity regulates extracellular tau in vivo
Kaoru Yamada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
Ann Brinkmalm et al.
MOLECULAR NEURODEGENERATION (2014)
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer's Disease
Tara L. Spires-Jones et al.
NEURON (2014)
Much of Late Life Cognitive Decline Is Not due to Common Neurodegenerative Pathologies
Patricia A. Boyle et al.
ANNALS OF NEUROLOGY (2013)
Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology
Beatriz G. Perez-Nievas et al.
BRAIN (2013)
Synaptic alterations in the rTg4510 mouse model of tauopathy
Katherine J. Kopeikina et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2013)
Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease
Steven E. Arnold et al.
NEUROBIOLOGY OF AGING (2013)
Neurotoxicity of Amyloid β-Protein: Synaptic and Network Dysfunction
Lennart Mucke et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Cognitive reserve, presynaptic proteins and dementia in the elderly
W. G. Honer et al.
TRANSLATIONAL PSYCHIATRY (2012)
Amyloid-β/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson et al.
JOURNAL OF NEUROSCIENCE (2011)
Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
Moustapha Cisse et al.
NATURE (2011)
Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
Irina Kuperstein et al.
EMBO JOURNAL (2010)
Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
Hans Zempel et al.
JOURNAL OF NEUROSCIENCE (2010)
Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
Brian R. Hoover et al.
NEURON (2010)
A Novel Mechanism and Treatment Target for Presynaptic Abnormalities in Specific Striatal Regions in Schizophrenia
Vilte E. Barakauskas et al.
NEUROPSYCHOPHARMACOLOGY (2010)
The Neuropathology of Probable Alzheimer Disease and Mild Cognitive Impairment
Julie A. Schneider et al.
ANNALS OF NEUROLOGY (2009)
Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
Robert M. Koffie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice:: Synaptotoxicity without plaque formation
L Mucke et al.
JOURNAL OF NEUROSCIENCE (2000)
Share Paper
